April 15, 2026

GlycoNex secures Japan’s PMDA approval for GNX1021 Phase I trial

​GlycoNex has received Japan’s PMDA approval to commence a first-in-human Phase I clinical trial of GNX1021, its lead ADC candidate,...

April 15, 2026

AIP to acquire Avanos Medical for $1.27bn

​Avanos Medical is to be acquired by affiliates of AIP in an all-cash transaction that values the company at an...

April 15, 2026

Lilly to acquire CrossBridge Bio for up to $300m

​Eli Lilly and Company has agreed to acquire all outstanding shares of CrossBridge Bio for up to $300m in cash.The...

April 14, 2026

J&J reports 12-month data for Varipulse PFA platform

​J&J has reported interim 12-month results from the VARIPURE study, assessing the effectiveness and safety of its Varipulse PFA platform...

April 14, 2026

Vir Biotechnology doses first patient in Phase I VIR-5500 trial

​Vir Biotechnology has dosed the first patient in one of three expansion cohorts in its ongoing Phase I clinical trial...

April 14, 2026

MSD, Daiichi Sankyo’s ifinatamab deruxtecan receives FDA priority

​MSD and Daiichi Sankyo have received priority review from the FDA for ifinatamab deruxtecan’s BLA to treat ES-SCLC.The post MSD,...

April 13, 2026

Zebra Technologies and Aiva Health team up on nurse solutions

​Zebra Technologies and Aiva Health have collaborated for supporting hands-free nurse workflows with Aiva's AI-powered solution.The post Zebra Technologies and...

April 13, 2026

FDA issues complete response letter to Replimune’s RP1 for melanoma

​The FDA has issued a complete response letter to Replimune’s biologics license application concerning the RP1 therapy.The post FDA issues...

April 13, 2026

BioNTech and DualityBio report positive data for trastuzumab pamirtecan

​BioNTech and DualityBio reported encouraging data from a Phase II cohort of their study evaluating the efficacy of trastuzumab pamirtecan.The...

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.